Genetically modified rules: the awkward rule–exception–right distinction in EC–Biotech

Tomer Broude

World Trade Review, 2007, vol. 6, issue 2, 215-231

Abstract: The arcane distinction between ‘rules’, ‘exceptions’, and ‘autonomous rights’ has troubled WTO dispute settlement since its earliest days, primarily with respect to procedural burden-of-proof questions. Yet in its report, the EC–Biotech panel relied on a techno-textual understanding of this distinction to interpret the substantive applicability of Articles 2.2, 5.1, and 5.7 SPS – the WTO’s fundamental rules on the degree of scientific certainty of risk required to allow a state to restrict imports of goods due to human, animal, or plant health or life concerns. This article critiques the panel’s approach on the backdrop of WTO jurisprudence and deontic logic, arguing that the norm-category of ‘autonomous rights’ does not actually exist; that the Article 2.2–5.1/5.7 SPS relationship should be more straightforwardly construed than the panel’s analysis would suggest; and that the disorderly and incoherent outcome of the panel’s analysis serves as a cautionary tale against excessive textualism in WTO dispute settlement.

Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:wotrrv:v:6:y:2007:i:02:p:215-231_00

Access Statistics for this article

More articles in World Trade Review from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().